Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Unbranded Hypertension Ad Cited For Link To Diovan Promotion

Executive Summary

Novartis has had two conference calls with FDA's Division of Drug Marketing, Advertising & Communications to discuss the agency's concerns about unbranded ads connected with the company's direct-to-consumer Diovan (valsartan) campaign

You may also be interested in...



Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer

Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says

Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer

Similarities between branded ads and disease awareness ads may benefit consumers and should not be prohibited by FDA, Pfizer says

Novartis To Consider “Off Shoring” Some Corporate Functions To India

Novartis will consider "off shoring" certain corporate functions to India

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS044396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel